Mov Disord Vol 31, Suppl 2 Archives - Page 47 of 207 - MDS Abstracts

2016 International Congress
Dementia in Parkinson’s disease: Is male gender a risk factor?
E. Cereda, R. Cilia, C. Klersy, C. Siri, A. Colombo, B. Pozzi, E. Reali, A.L. Zecchinelli, C.B. Mariani, S. Tesei, M. Canesi, G. Sacilotto, N. Meucci, M. Zini, I.U. Isaias, M. Barichella, E. Cassani, S. Glodwurm, G. Pezzoli (Pavia, Italy)
Objective: We investigated the relationship between dementia and gender along with other established risk factors, such as age and disease duration. Background: The rates of…
2016 International Congress
Is physiotherapy an effective for treatment of Parkinson’s disease?!
R. Agzamov, S. Tursunov, G. Rakhimbaeva, F. Yunusov, D. Lutfullaeva, J. Olimov, A. Kalendarev, K. Abdukhalimova, R. Mirzaev (Tashkent, Uzbekistan)
Objective: Aim of investigation was to evaluate the effectiveness of physiotherapy intervention compared with no intervention in patients with PD. Background: In spite of various…
2016 International Congress
Neural mechanisms underlying step initiation failure in patients with Parkinson’s disease and freezing of gait
M. Gilat, M. Georgiades, J.M. Shine, K.A. Ehgoetz Martens, C.C. Walton, J.M. Hall, S.J.G. Lewis (Sydney, Australia)
Objective: To investigate the neural mechanisms underlying gait initiation failure in Parkinson's disease patients with Freezing of Gait. Background: Freezing of Gait (FOG) is a…
2016 International Congress
Comparison of DAT and DOPA PET tracer for assessing severity and progression in patients with Parkinson’s disease
W. Li, N.P. Lao-Kaim, A.A. Roussakis, A. Martin-Bastida, C. Loane, N. Valle-Guzman, Z. Kefalopoulou, M. Politis, T. Foltynie, R.A. Barker, P. Piccini (London, United Kingdom)
Objective: The aims of this study were to quantify striatal uptake of 18F-DOPA and 11C-PE2I in the same group of PD patients, to assess the…
2016 International Congress
Diagnostic reliability of clinical symptoms in patients with incomplete manifestation of the triad of parkinsonism compared to 18F-DOPA PET-CT MRI imaging
C. Peralta, T. Soto Depetris, A. Perez, F. Biafore, J. Gili, A. Valda, D. Menna, M. Aguilar, H. Corradini, M. Bastianello (Caba, Argentina)
Objective: To describe the diagnostic reliability of the triad of clinical symptoms compared to the uptake of 18 F-DOPA PET-CT fusion MRI scan. To compare…
2016 International Congress
The effect of an eight-week mindfulness training intervention on emotion related brain activation in people with Parkinson’s disease
B.A. Pickut, W. Van Hecke, P. Cras, E. Kerckhofs, S. Vanneste, D. Crosiers, P. Marien, P.M. Parizel (Grand Rapids, MI, USA)
Objective: The aim of the current study is to investigate the effect of an eight-week mindfulness training intervention on emotion related brain activation in people…
2016 International Congress
Is the selection of stepping impaired in PD in ON state?
C. Stummer, E. Mallia, J. Rothwell, B.R. Bloem, V. Weerdesteyn (Nijmegen, Netherlands)
Objective: To compare the selection of stepping actions during a probability reaction time task in people with Parkinson's disease (PD) in the ON state with…
2016 International Congress
Intraoperative localization of beta band and high-frequency oscillations within the subthalamic nucleus
B.C.M. van Wijk, A. Pogosyan, T. Foltynie, M.I. Hariz, P. Limousin, L. Zrinzo, P. Brown, V. Litvak (London, United Kingdom)
Objective: To investigate whether beta band activity (13-30Hz) and high-frequency oscillations (150-400Hz) arise from the same spatial location within the subthalamic nucleus (STN) of Parkinson's…
2016 International Congress
Detection of primary olfactory cortex dysfunction in early-stage Parkinson’s disease
J. Wang, T. Subramanian, Q.X. Yang (Hershey, PA, USA)
Objective: To detect the functional changes of primary olfactory cortex (POC) in the early-stage Parkinson's disease (PD) using functional magnetic resonance imaging (fMRI). Background: Olfactory…
2016 International Congress
Diagnosis and management of dementia with Lewy bodies: Influence of concomitant cerebrovascular disease
A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russia)
Objective: We assume that the cerebrovascular disease might influence on the course and clinical features of dementia with Lewy bodies (DLB). The aim of this…